| PERIOD ENDING | 25-Jan-09 | 27-Jan-08 | 28-Jan-07 | | Total Revenue | 294,820 | 284,790 | 252,538 | | Cost of Revenue | 135,233 | 128,513 | 115,564 | | | Gross Profit | 159,587 | 156,277 | 136,974 | | | Operating Expenses | | Research Development | 41,405 | 43,064 | 41,256 | | Selling General and Administrative | 72,890 | 74,263 | 71,853 | | Non Recurring | 3,401 | (5,339) |
-
| | Others |
-
| 1,102 |
-
| | | | Total Operating Expenses |
-
| 113,090 |
-
| | | | Operating Income or Loss | 41,891 | 43,187 | 23,865 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 4,290 | 15,131 | 13,697 | | Earnings Before Interest And Taxes | 46,181 | 58,318 | 37,562 | | Interest Expense | 3 | 11 | 151 | | Income Before Tax | 46,178 | 58,307 | 37,411 | | Income Tax Expense | 8,657 | 10,524 | 6,283 | | Minority Interest |
-
|
-
|
-
| | | | Net Income From Continuing Ops | 37,521 | 47,783 | 31,128 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
| | Other Items |
-
|
-
|
-
| | | | Net Income | 37,521 | 47,783 | 31,128 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $37,521 | $47,783 | $31,128 |
|
1.48% Nasdaq 
Income Statement
